Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2006Emerging infectious diseasesOpen Access

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMaría Elvira BalcellsPontificia Universidad Católica de ChileSTSara L. ThomasLondon School of Hygiene & Tropical MedicinePGPeter Godfrey‐FaussettLondon School of Hygiene & Tropical Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Balcells et al. (2006) studied this question.

synapsesocial.com/papers/6a8248347a56cf6465ffb3bbhttps://doi.org/10.3201/eid1205.050681
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment1999 · 620 citations
  2. 2Effect of Isoniazid upon the Reactivation of Inactive Tuberculosis1965 · 17 citations
  3. 3A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection1989 · 1,585 citations
  4. 4A prospective study of the risk of tuberculosis among HIV-infected patients1993 · 177 citations